ReviewPharmaceutics2024

Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.

Theodora Katopodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.